When the heavy emptiness of depression and the racing tightness of anxiety collide, finding relief can feel impossible. TMS Therapy for anxious depression offers a targeted, non-invasive way to quiet the mind and lift the weight when traditional treatments fall short.
Average reduction in both GAD-7 (anxiety) and PHQ-9 (depression) scores after a full TMS course in real-world clinical studies
Of patients with treatment-resistant depression show some improvement with TMS, including those with anxious features
Sessions over approximately 4–6 weeks comprise a standard TMS course for anxious depression (5 sessions per week)
Seizure risk per patient — comparable to or lower than some antidepressants when proper screening is followed
TMS is FDA-cleared for adults with major depressive disorder who have not had sufficient benefit from antidepressant medications. The clearance includes the reduction of anxiety symptoms when they present alongside major depressive disorder — meaning TMS for anxious depression is not off-label use.
The NeuroStar Advanced Therapy System, which we use at Embracing Life Wellness Center, received FDA clearance for treating depression in 2008. The FDA has recognized that TMS produces meaningful anxiety reduction in patients with comorbid anxiety and depression. Deep TMS systems (BrainsWay) have also been studied specifically for anxious depression, showing significantly lower anxiety and depression severity compared to placebo stimulation in clinical trials.
Important distinction: The FDA clearance for depression includes patients with anxious features. You do not need a separate “anxiety protocol” clearance. The standard TMS protocol for depression — high-frequency stimulation to the left dorsolateral prefrontal cortex — has repeatedly been shown to reduce both mood and worry symptoms simultaneously.
The clearance applies to adults aged 18 and older. For adolescents aged 15–17 with anxious depression, TMS remains FDA-cleared specifically for major depressive disorder, not as a standalone anxiety treatment. Dr. Fickey can discuss individual circumstances during consultation.
The table below reflects the specific presentation of anxious depression — not mild or situational distress, but the kind that has already survived medication trials and still has a grip.
Symptom Domain
Depressed mood with tension
Restlessness
Worry that sticks
Sleep disturbance
Fatigue that feels physical
Concentration collapse
Irritability
Avoidance
Common impact on daily life
Constant heaviness plus physical tightness; can’t relax even when nothing is wrong
Inability to sit still; fidgeting; feeling “wired but tired” all day
Thoughts loop on worst-case scenarios; reassurance-seeking doesn’t help
Difficulty falling asleep (anxiety) plus early morning waking (depression); exhausted but can’t rest
Body feels heavy; moving through molasses; but mind won’t stop racing
Can’t follow conversations or finish tasks; brain fog plus distractibility from worry
Snapping at people; low frustration tolerance; then feeling guilty about it
Canceling plans, skipping work, staying home because everything feels overwhelming
When these symptoms persist despite adequate SSRI trials (typically 8–12 weeks at therapeutic dose) and a genuine attempt at therapy, TMS therapy for anxiety and depression offers a proven next step.
Standard antidepressants work systemically. A pill enters your bloodstream, crosses the blood-brain barrier, and alters serotonin or norepinephrine everywhere in the brain. That’s why side effects — weight gain, sexual dysfunction, emotional blunting — are so common. The medication can’t tell the difference between the circuits causing depression and the circuits regulating appetite or libido.
TMS for anxious depression works locally, not systemically.
Here’s the mechanism. Using the NeuroStar Advanced Therapy System, we deliver focused magnetic pulses through the scalp and skull. These pulses induce small electrical currents in the underlying brain tissue. The primary target is the left dorsolateral prefrontal cortex (L-DLPFC) — a region that governs mood regulation, impulse control, and executive function.
But here’s what matters for anxious depression. The prefrontal cortex doesn’t work in isolation. It connects directly to deeper emotion-related structures — the amygdala, the anterior cingulate cortex, the limbic system. When the prefrontal cortex is underactive (which happens in depression and anxiety), those deeper structures run unchecked. Anxiety spikes. Mood plummets.
Think of it this way. The prefrontal cortex is the brake pedal. The amygdala is the gas pedal. In anxious depression, the brake is weak and the gas is stuck. TMS strengthens the brake. Over repeated sessions, the prefrontal cortex gets better at sending inhibitory signals downward. The amygdala calms down. The loop between worry and low mood loses its grip.
Unlike medication, nothing circulates in your bloodstream. No weight gain. No sexual side effects. No emotional numbness. You’re awake the entire time. You drive yourself home afterward.
How TMS Therapy Works
A full course of TMS therapy for anxious depression typically runs 4–6 weeks, with sessions five days per week. Below is the step-by-step experience at Embracing Life Wellness Center.
Call (813) 662-5919. We’ll discuss what you’ve tried, what hasn’t worked, and whether TMS fits your clinical picture. No pressure. No obligation.
Dr. Melissa Fickey — board-certified child, adolescent, and adult psychiatrist — completes a full assessment. She reviews your depression and anxiety symptom profile, prior medication trials (including doses and durations), previous therapy experiences, and any contraindications like metal implants in the head or seizure history.
We determine your individual motor threshold — the minimum pulse intensity needed to produce a small thumb twitch. This calibrates the device to your brain, not an average from a textbook. The coil is positioned over your left dorsolateral prefrontal cortex using a standardized measurement system. First session lasts about 60–90 minutes.
Step 4: Daily Stimulation Sessions
You recline in a treatment chair. The NeuroStar coil delivers focused magnetic pulses to the left DLPFC. Session duration: approximately 19–37 minutes. You feel a tapping or clicking sensation on the scalp. Some patients describe it as a woodpecker. It’s not painful, though the first few sessions can feel unusual. You remain fully awake. Bring headphones. Watch a video on your phone. Whatever helps you relax.
The moment the session ends, you’re done. No sedation. No recovery room. No missed work. You drive yourself home or go back to the office. The only after-effect some people notice is mild scalp tenderness or a brief headache, similar to the feeling after wearing tight headphones for too long.
Five sessions per week for roughly 4–6 weeks. Some patients need more. Some need a maintenance schedule afterward — one session per week or a brief refresher course every few months. We reassess at week three or four to see how you’re responding.
Book Your Appointment and Build Your Custom Timeline
Feature
FDA Clearance
Invasiveness
Systemic Side Effects
Time to Response
Works When Meds Have Failed
Requires Ongoing Medication
Recovery Time Per Session
Insurance Coverage
TMS (Anxious Depression)
✓ MDD with anxiety features
Noninvasive — no anesthesia, no IV
None — mild scalp tapping only
2–6 weeks
✓ Primary indication
No
None — drive yourself
Increasing with prior authorization
SSRIs
✓ Multiple agents
Systemic (oral daily)
Weight gain, sexual dysfunction, emotional blunting, nausea
8–12 weeks
No
Yes (daily)
N/A
Routinely covered
CBT
✓ First-line
Noninvasive
None
8–20 sessions
Yes, but harder when severely depressed
No
None
Routinely covered
Ketamine (IV/Spravato)
✓ Treatment-resistant depression
IV infusion or nasal spray; requires monitoring
Dissociation, nausea, sedation, potential for abuse
Hours to days (ketamine); weeks (Spravato)
✓ For refractory cases
Maintenance sessions typically required
2+ hours monitoring required
Limited; prior auth required
Insurance coverage for TMS for anxious depression has expanded significantly since the FDA clearance in 2008. However, policies vary dramatically between carriers and even between plans from the same carrier.
Aetna (requires prior authorization; coverage varies by plan)
Blue Cross Blue Shield (Florida plans increasingly cover with medical necessity documentation)
Cigna (case-by-case; requires documented treatment resistance)
UnitedHealthcare / Optum (some plans cover; pre-authorization required)
Tricare (coverage varies; pre-authorization required)
Most commercial PPO plans (coverage is not automatic but can often be obtained with proper documentation)
Confirmed DSM-5 diagnosis of major depressive disorder (anxious features are included under this diagnosis)
Age 18 or older (FDA clearance for TMS is adult-only; adolescent coverage is for MDD without separate anxiety indication)
Documented treatment resistance — typically failure of at least two adequate antidepressant trials (8–12 weeks each at therapeutic dose) OR intolerance to medication side effects
Previous or concurrent psychotherapy (often CBT)
No contraindications (metal implants in head, seizure disorder, certain intracranial hardware)
Yes, if you meet criteria for treatment-resistant major depressive disorder. The anxiety component is not separately required for coverage; it’s considered a feature of your depression diagnosis. Most commercial plans require documented failure of at least two antidepressants at adequate doses and durations (typically 8–12 weeks each). Our billing team verifies benefits before you start. Call (813) 662-5919 for a free benefits check.
The core protocol is the same — high-frequency stimulation to the left dorsolateral prefrontal cortex. The difference is that patients with anxious depression often experience significant anxiety reduction alongside mood improvement. Some clinics may add low-frequency stimulation to the right DLPFC for an additional anxiety-targeting effect, but the standard left-sided protocol is FDA-cleared and well-studied for both symptoms. A 2021 clinical review found that high-frequency left, low-frequency right, and bilateral TMS all appear effective in reducing both depression and anxiety.
TMS is FDA-cleared for major depressive disorder, not for GAD alone. However, many patients with GAD also have subsyndromal depression, and TMS can help both. For pure anxiety disorders without depression, the evidence is more limited. Dr. Fickey can discuss whether TMS is appropriate for your specific symptom profile during a psychiatric evaluation.
Yes. Most patients continue their current medications throughout TMS treatment. TMS is typically used as an adjunct — an add-on — not a replacement for medication that is partially helping. If your medication is causing intolerable side effects, we may discuss tapering after TMS is complete. Do not stop or change your medication regimen without consulting Dr. Fickey.
The “TMS dip” is a temporary worsening of symptoms that some patients experience around the halfway point of treatment — typically week two or three. Clinic documentation confirms that while anxiety is not a standard side effect, some patients report a “TMS dip” where symptoms temporarily worsen mid-treatment before improving. It usually lasts a few days to a week. It does not mean TMS is failing. Most patients who push through the dip go on to have strong responses. Your clinician will warn you about it beforehand and support you through it.
This varies significantly. Some people maintain improvement for six months or longer after a single course. Others notice symptoms gradually returning and benefit from a maintenance schedule — for example, one session per week or a brief two-week refresher course every few months. Real-world data shows that approximately 45% of patients have reduced symptoms one month after completing a full TMS course. Anxious depression patients may need maintenance more often than non-anxious patients, but the data on this is still emerging.
The FDA clearance for TMS in depression is for adults aged 18 and older. For patients aged 15–17, TMS is FDA-cleared for major depressive disorder (including anxious features) using the NeuroStar system. Dr. Fickey is board-certified in child and adolescent psychiatry and can discuss adolescent treatment during a consultation.
Response rates are high — roughly two-thirds to 80% show some improvement — but that means some people do not respond. Alternative options include medication adjustment (different class, augmentation, or switching), ketamine (IV infusion or Spravato nasal spray), ECT (for severe refractory cases), or investigational protocols like accelerated TMS. Dr. Fickey discusses realistic expectations before you start and has a plan for non-response.
In most patients, anxiety improves. A clinic review notes that while anxiety is not a listed side effect, there are indications that TMS can temporarily increase anxiety when treating depression. However, no evidence shows it worsens anxiety in most patients. Some patients experience a temporary increase in anxiety during the first week or two of treatment — sometimes called the “TMS dip” or an early activation syndrome. This is usually transient and resolves as treatment continues. Permanent worsening is rare. Your clinician will monitor you closely and can adjust protocol parameters if needed.
Yes. Embracing Life Wellness Center offers secure video telehealth for initial consultations and follow-up psychiatric appointments. The initial TMS mapping session and each treatment session must be in-person at one of our Florida locations — Riverview, Tampa, or Miami. Call (813) 662-5919 to schedule a telehealth consultation.
Our offices are open Monday through Friday from 8 a.m. to 5:30 p.m. for office visits and from 8 a.m. to 6 p.m for TMS treatments.